ClearPoint Neuro (CLPT) FCF Margin Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -473.00 |
| 10 | ClearPoint Neuro | 464.87 Mn | 435.47 Mn | 6.71 Mn | -3,762.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,762.00 |
| Mar 31, 2026 | 389.00 |
| Dec 31, 2025 | -9,733.00 |
| Sep 30, 2025 | -2,232.00 |
| Jun 30, 2025 | 553.00 |
| Mar 31, 2025 | -2,463.00 |
| Dec 31, 2024 | -191.00 |
| Sep 30, 2024 | 2,034.00 |
| Jun 30, 2024 | 5,677.00 |
| Mar 31, 2024 | 5,682.00 |
| Dec 31, 2023 | 4,252.00 |
| Sep 30, 2023 | 4,095.00 |
| Jun 30, 2023 | 653.00 |
| Mar 31, 2023 | -2,086.00 |
| Dec 31, 2022 | 2,385.00 |
| Sep 30, 2022 | -140.00 |
| Jun 30, 2022 | 1,066.00 |
| Mar 31, 2022 | -3,235.00 |
| Dec 31, 2021 | -1,923.00 |
| Sep 30, 2021 | -3,595.00 |